Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Zaher Nahle
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
[[File:Zaher Nahle.png|300px|thumb|right|Source: Solve ME/CFS Initiative solvecfs.org]] '''Zaher Nahle''', PhD, MPA, is a Lebanese-American scientist and executive with interdisciplinary training in administration and [[biomedical research]]. He previously served as Chief Scientific Officer (CSO) and Vice President for Research at [[Solve ME/CFS Initiative]] (SMCI).<ref name=":0">https://www.linkedin.com/in/zahernahle/</ref> He is now Chief Executive Officer of the Arthritis National Research Foundation, ANRF (www.Curearthritis.org). ==Education== *Bachelor's degree in Chemistry from American University of Beirut (1995) *Master in Public Administration (MPA) from Harvard University’s John F. Kennedy School of Government (2013) *Fellowship Certificate in Public Policy & Management from Harvard University’s John F. Kennedy School of Government (2013) *PhD in physiology and biophysics from Cold Spring Harbor Laboratory and Stony Brook University (2003) *Post-doctoral fellowships at both Harvard and Stony Brook (2003-04) ==Career== In the first part of his career, Dr. Nahle served as an Assistant Professor of Neurosurgery and Cancer Biology at [[Vanderbilt University Medical Center]]<ref>https://www.linkedin.com/in/zahernahle</ref> and founded a nonprofit organization focused on the [[disability]] agenda with a classmate while studying at [[Harvard University|Harvard]]. From June 2015 to February 2018, Dr. Nahle served as Chief Scientific Officer (CSO) and Vice President for Research at [[Solve ME/CFS Initiative]] (SMCI)<ref name=":0" /> where he oversaw a research and scientific portfolio that included a peer-review grant program for external investigators, specialized [[Biobanks|biobanking]] and patient registry platforms as well as numerous medical education initiatives for patients and healthcare professionals. He also directed a specialized investment program with medical centers, government agencies and industry partners to accelerate the discovery process in the ME/CFS research. He is now Chief Executive Officer of the Arthritis National Research Foundation, ANRF (www.Curearthritis.org). ANRF has earned a four-star (i.e. top) rating from [[Charity Navigator]] nine years in a row,<ref>{{Cite web|url=https://curearthritis.org/transparency-accountability-best-charities/ | title = Best Charities {{!}} Transparency and Accountability|website=Arthritis Research {{!}} Arthritis National Research Foundation|language=en-US|access-date=2019-01-30}}</ref> and is dedicated to funding innovative research to understand the causes of [[osteoarthritis]], [[rheumatoid arthritis]], [[lupus]], juvenile arthritis, [[fibromyalgia]] and related [[Autoimmune disease|autoimmune]] and [[Inflammation|inflammatory]] conditions. Dr. Nahle often speaks at international conferences and serves on committees at US federal agencies, including the [[NIH]] and the [[Centers for Disease Control and Prevention|CDC]]. His background includes [[cancer]] biology, high-throughput technologies, [[diabetes]], and ME/CFS. His work is featured in journals like Science and Nature. He was an awardee of the American Heart Association (AHA) and the Department of Defense (DoD) and a Mason fellow at Harvard's John F. Kennedy School of Government. ==Awards== *Department of Defense Breast Cancer Fellowship Award - Congressionally Directed Medical Research Programs - Outstanding score (2000) *American Heart Association (AHA) career development award BGIA - Outstanding score (2008) *National Priorities Research Program - Qatar Foundation (2010) *American Cancer Society (ACS) Scholar (pay if) - Outstanding score (2011) *Harvard Kennedy School Scholarship (2013) *Robert Wood Johnson Foundation PEER White Label Award - for the establishment and implementation of a national Patient Registry and Electronic Health Information (EHI) system for [[ME/CFS]] (2016) <ref>https://solvecfs.org/smci-receives-robert-wood-johnson-foundation-award/</ref> ==National committees and advocacy== *Oct 2016 - present – Member of [[Centers for Disease Control and Prevention|CDC]] Technical Development Working Group *Jan 2017 - present – Member of the Baseline/Covariate Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].<ref>{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138 | title = Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster | last= | first = | author-link =| date = |website=NIH|archive-url=|archive-date=|url-status=|access-date=2019-10-11}}</ref> This working group reviewed data collection instruments widely used by investigators in the [[ME/CFS]] field, and either recommended their use unchanged or (more often) proposed some modifications.<ref>https://www.commondataelements.ninds.nih.gov/Doc/MECFS/Baseline_Covariate_Information_Subgroup_Summary.pdf</ref> *Mar 8, 2017 – Written Public Testimony from the [[Solve ME/CFS Initiative]] to the House Committee on Appropriations, Subcommittee on Labor Health & Human Services *May 17, 2017 – Rare Disease Legislative Advocates (RDLA), EveryLife Foundation legislative meeting in Washington, DC – Ensuring [[NIH]] Funding Benefits Science and Discovery in Rare and Neglected Diseases *May 18, 2017 – Congressional Briefing on [[ME/CFS]] - [https://www.youtube.com/watch?v=Najd5O7usnQ/ Recording of Congressional Briefing on ME/CFS] - [http://solvecfs.org/wp-content/uploads/2017/05/InvisibleCrisis_wide_051817-print.pdf/ (Slides of briefing)] * Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care<ref>{{Cite journal | last = Friedman | first = Kenneth | authorlink = Kenneth Friedman | last2 = Bateman | first2 = Lucinda | author-link2 = Lucinda Bateman | last3 = Bested | first3=Alison C. | author-link3 = Alison Bested | last4 = Nahle | first4 = Zaher | author-link4 = Zaher Nahle | date = Aug 2019 | title = Editorial: Advances in ME/CFS Research and Clinical Care|url=https://www.frontiersin.org/articles/10.3389/fped.2019.00370/full|journal=Frontiers in Pediatrics|volume=|issue=|pages=|doi=10.3389/fped.2019.00370|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fped.2019.00370/full (Full text)] ==Interviews & Talks== *19 November 2015 – “Get Your Motor Running” – Zaher Nahle Takes on [[Chronic Fatigue Syndrome]] by [[Cort Johnson]]<ref>{{Cite web|url=https://www.healthrising.org/blog/2015/11/19/zaher-nahle-takes-on-chronic-fatigue-syndrome/ | title = "Get Your Motor Running" - Zaher Nahle Takes on Chronic Fatigue Syndrome | last = Johnson | first =Cort | date = 2015-11-19 | website = Health Rising|language=en-GB|access-date=2019-09-03}}</ref> *15 December 2016 – [[Solve ME/CFS Initiative]] [https://www.youtube.com/watch?v=_LuN25To0As/ Webinar - Progress and Challenges in ME/CFS with Zaher Nahle, PhD, MPA] *Jan 25, 2017 – Session Chair and speaker at the 2017 Precision Medicine World Conference in Silicon Valley – Topic: [[ME/CFS]]: The Mysterious Illness Science Has Yet to Unravel<ref>{{Cite web|url=https://www.pmwcintl.com/past/sessionthemes-mecfs-the-mysterious-illness-science-has-yet-to-unravel/ | title = ME/CFS: The Mysterious Illness Science Has Yet to Unravel Session Chair: Zaher Nahle, Solve ME/CFS Initiative | website = PMWC Precision Medicine World Conference|language=en-US|access-date=2019-09-03}}</ref> *24 May 2017 – Session Chair and speaker at the Precision Medicine World Conference (PMWC) 2017 at Duke - Topic: [[ME/CFS]]: The Mysterious Illness Science Has Yet to Unravel<ref>{{Cite web|url=http://www.bioquicknews.com/node/4263 | title = ME/Chronic Fatigue Syndrome Takes Center Stage on First Afternoon of Personalized Medicine World Conference (PMWC) 2017 at Duke {{!}} www.bioquicknews.com|website=bioquicknews.com|access-date=2019-09-03}}</ref><ref>{{Cite web|url=http://2017duke.pmwcintl.com/sessionthemes-mecfs-the-mysterious-illness-science-has-yet-to-unravel/ | title = ME/CFS: The Mysterious Illness Science Has Yet to Unravel Session Chair: Zaher Nahle, Solve ME/CFS Initiative | website = Precision Medicine World Conference 2017 Duke|language=en-US|access-date=2019-09-03}}</ref> *31 May 2017 – Speaker at the 7th [[Invest in ME]] [[Biomedical Research into ME Colloquium]] in London – [[Diagnostic biomarker|Biomarkers]] in [[ME/CFS]]<ref>http://solvecfs.org/wp-content/uploads/2017/06/BRMEC7-Colloquium-2017-Welcome-to-London.pdf</ref> *14 October 2017 – Convener of the [[Solve ME/CFS Initiative]] Discovery Forum 2017: A New Era in ME/CFS Research – [http://solvecfs.org/october-2017-research-1st-dr-nahle-letter/ Editorial Letter from Dr. Nahle] and [http://solvecfs.org/a-new-era-in-mecfs-research-presentation-summaries-from-discovery-forum-2017/ Presentation Summaries from the Discovery Forum] *17 October 2017 – White House Chronicle with [[Llewellyn King]] - [https://www.youtube.com/watch?v=wDKhoLIJ_9w&feature=youtu.be%2F Chronic Fatigue Syndrome: a disease hidden in plain sight]<ref>{{Citation | title = Chronic Fatigue Syndrome: a disease hidden in plain sight {{!}} White House Chronicle|url=https://www.youtube.com/watch?v=wDKhoLIJ_9w|language=en|access-date=2019-09-03}}</ref> ==Open Letter to ''The Lancet''== Two [[open letter to the Lancet | open letters to the editor of ''The Lancet'']] urged the editor to commission a fully independent review of the [[PACE trial]], which the journal had published in 2011. In 2016, Dr. Nahle, along with 41 colleagues in the [[ME/CFS]] field, signed the second letter. *10 February 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] ==Blog Posts and Editorials (selected)== ===2015=== *Winter 2015 Chronicle, [https://issuu.com/solvemecfsinitiative/docs/chronicle_winter2015/6/ Overcoming the Challenges of a Complex Disease] *4 December 2015, [http://solvecfs.org/zaher-letter-december/ SMCI Research 1st Letter] *14 September 2015, [http://solvecfs.org/%3Fp%3D6954/ Did Darwin Have ME/CFS?] *21 August 2015, [http://solvecfs.org/i-thought-it-was-a-typo/ I Thought It Was a Typo…] *7 August 2015, [http://solvecfs.org/nahle-letter/ SMCI Research 1st Letter] ===2016=== *16 December 2016, [http://solvecfs.org/december-research-1st-dr-nahles-letter/ SMCI Research 1st Letter] *11 November 2016, [http://solvecfs.org/november-research-1st-dr-nahles-letter/ SMCI Research 1st Letter] *16 September 2016, [http://solvecfs.org/september-zaher-letter/ SMCI Research 1st Letter] *12 August 2016, [http://solvecfs.org/august-2016-zaher-letter/ SMCI Research 1st Letter] *6 May 2016, [http://solvecfs.org/may-2016-zaher-letter/ SMCI Research 1st Letter] *15 April 2016, [http://solvecfs.org/april-2016-zaher-letter/ SMCI Research 1st Letter] *9 February 2016, [http://solvecfs.org/February+2016+Letter+from+Dr.+Zaher+Nahle/ SMCI Research 1st Letter] ===2017=== *21 September 2017, [http://solvecfs.org/september-2017-research-1st-dr-nahle-letter/ SMCI Research 1st Letter] *19 July 2017, [http://solvecfs.org/july-2017-research-1st-dr-nahle-letter/ SMCI Research 1st Letter] *14 April 2017, [http://solvecfs.org/april-2017-research-1st-dr-nahle-letter/ SMCI Research 1st Letter] *Spring 2017 SMCI Chronicle, [http://solvecfs.org/wp-content/uploads/2017/06/Chronicle-Spring-2017.pdf 7 Research Lessons from the Lab Bench of Dr. Nahle] *10 February 2017, [http://solvecfs.org/february-2017-research-1st-dr-nahle-letter/ SMCI Research 1st Letter] ===2018=== *https://www.curearthritis.org/zaher-nahle/ ==Online presence== *[http://www.zahernahle.net/ Website] *[https://www.linkedin.com/in/zahernahle LinkedIn] *[https://www.facebook.com/znahle/ Facebook] *[https://twitter.com/solvecomplexD Twitter] == References == {{Reflist}} [[Category:Researchers]] [[Category:US researchers]] [[Category:Psychological paradigm critics]] [[Category:PACE trial critics]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Citation
(
edit
)
Template:Cite journal
(
edit
)
Template:Cite web
(
edit
)
Template:Main other
(
edit
)
Template:Reflist
(
edit
)
Module:Check for unknown parameters
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:No globals
(
edit
)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs